Gut Bacteria May Hold the Key to Bariatric Surgery's Diabetes Benefits

A new study in Nature Metabolism has examined how bariatric surgery alters gut bacteria and improves metabolic health. The research, led by Olsson, Borgeraas, Chakaroun, and colleagues, reveals that changes in the gut microbiome may explain why some patients experience remission of type 2 diabetes soon after surgery—even before major weight loss occurs. These findings suggest that specific bacterial profiles could predict which patients will benefit most from the procedure. Bariatric surgery is known to deliver metabolic benefits beyond weight reduction, including rapid improvements in type 2 diabetes. To explore this link, researchers used advanced metagenomic sequencing to analyse the gut microbiota of patients before and after surgery. Their results showed a significant shift in the microbial ecosystem, with increased diversity and the emergence of certain bacterial species.

The study identified distinct microbial signatures in patients whose diabetes went into remission post-surgery. These beneficial bacteria appeared to enhance the production of short-chain fatty acids (SCFAs), which reduce inflammation and help regulate appetite and energy use. Some of these microbial changes occurred quickly, matching early metabolic improvements, while others developed more gradually. Further analysis revealed that specific bacterial groups enriched after surgery could alter bile acid metabolism. These changes activate key host receptors involved in controlling blood sugar and fat levels. Together, the shifts in gut bacteria influence multiple metabolic pathways, including inflammation, SCFA production, and bile acid regulation—all of which contribute to the surgery’s broader health effects.

The research highlights a clear connection between post-surgery gut microbial changes and improved metabolic outcomes. Patients with certain bacterial profiles were more likely to achieve diabetes remission, pointing to potential biomarkers for surgical success. These insights could help refine patient selection and optimise treatment strategies for those undergoing bariatric procedures.